For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221222:nRSV5417Ka&default-theme=true
RNS Number : 5417K TruFin PLC 22 December 2022
22 December 2022
TruFin plc
("TruFin" or the "Company")
Rejected Indicative Offer for Oxygen
TruFin announces that it recently received a non-binding, indicative offer for
Oxygen Finance Limited ("Oxygen") which values Oxygen at £26 million (the
"Offer"). After considering the terms of the Offer, the Board of TruFin has
rejected the Offer on the basis that it undervalues the business and prospects
of Oxygen.
The information contained within this Announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit)
Regulations 2019. By the publication of this Announcement via a Regulatory
Information Service, this inside information is now considered to be in the
public domain. The person responsible for arranging for the release of this
Announcement on behalf of the Company is Annie Styler.
For further information, please contact:
TruFin plc 0203 743 1340
James van den Bergh, Chief Executive Officer
07779 229508
Kam Bansil, Investor Relations
Liberum Capital Limited (Nominated Adviser and Corporate broker) 0203 100 2000
Chris Clarke
Edward Thomas
TruFin plc is the holding company for an operating group of companies that are
niche lenders and early payment providers. TruFin Group combines the benefits
of both the traditional relationship banking model and developments in the
fintech sector. The Company was admitted to AIM in February 2018 and trades
under the ticker symbol: TRU. More information is available on the Company
website www.TruFin.com (http://www.TruFin.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END OUPDGBDDDXDDGDB